Company / R&D Expense
MUSTANG BIO, INC. R&D Expense History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$21.1M
FY2019
5-year range
$100.0K / $21.1M
FY2016-FY2019
Trend
+905.0%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense changed +905% YoY in FY2019, a notable deviation from the 3-year average annual change of +937%.
Based on SEC 10-K filings.
$21M in FY2019 with a 3-year CAGR of +141.4%.
Improved from $100,000 to $21M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +141.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +141.4%, indicating consistent growth.
- In FY2019, r&d expense increased 905.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.37 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $21.1M | +905.0% |
| FY2018 | $2.1M | +2000.0% |
| FY2017 | $100.0K | -93.3% |
| FY2016 | $1.5M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026